Corporate ActionJun 29, 2026, 05:32 PM
Aura Biosciences Seeks to Boost Authorized Shares to 500M
AI Summary
Aura Biosciences, Inc. will hold a Special Meeting of Stockholders on August 5, 2026, to vote on two key proposals. The primary proposal seeks to amend the Company's charter to increase the authorized common stock from 150 million to 500 million shares, providing flexibility for future capital raising, strategic transactions, and equity incentives. Additionally, stockholders will vote on amending the 2021 Stock Option and Incentive Plan to include pre-funded warrants in the evergreen provision calculation for annual share increases.
Key Highlights
- Special Meeting of Stockholders scheduled for August 5, 2026.
- Proposal to increase authorized common stock from 150,000,000 to 500,000,000 shares.
- Current authorized shares are 150,000,000.
- Issued and outstanding shares: 103,397,416 as of June 1, 2026.
- Total share usage (issued + reserved) is 135,371,499, representing 90% of current authorized.
- Proposal to amend 2021 Stock Option Plan to include pre-funded warrants in evergreen calculation.
- 7,371,435 pre-funded warrants outstanding as of June 1, 2026.
- Record date for voting is June 12, 2026.
Price Impact
More from AURA